
?Cardiomyopathies: Types, Diagnosis, and Treatment
?The provided sources offer a comprehensive overview of several cardiomyopathies, beginning with Dilated Cardiomyopathy (DCM), explaining its characteristics, causes (including genetic factors), diagnostic methods like echocardiography and CMR, and treatment approaches.
?It then transitions to Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC), detailing its stages, characteristic electrocardiographic findings, and genetic underpinnings involving desmosomal proteins.
?The discussion broadens to include Takotsubo cardiomyopathy (TC), often stress-induced and reversible, and Tachycardia-induced cardiomyopathy, a reversible condition linked to prolonged rapid heart rates.
?Finally, Peripartum cardiomyopathy (PPCM), occurring during or after pregnancy, and Alcoholic Cardiomyopathy, caused by excessive alcohol consumption, are described, emphasizing their clinical presentations, risk factors, and management, often noting their shared features with general heart failure treatments and the importance of genetic evaluation and counseling across various cardiomyopathy types.
Meet our chief faculty, a European board-certified cardiac electrophysiologist with atrial fibrillation expertise, extensive research, international teaching, and a commitment to affordable, high-quality video content.
Explore coronary microvascular dysfunction in women, detailing its diagnosis, adverse prognosis, and evidence-based management including statins, ACE inhibitors, aspirin, lifestyle changes, and therapies that improve coronary flow reserve.
Align heart failure diagnosis with ESC guidelines by prioritizing chest x-ray, echocardiography, BNP testing, and ECG to enable timely, evidence-based management.
Explore the rising heart failure burden in India and South Asia, noting higher mortality, hospitalizations, and quality of life decline, with risk factors like hypertension, diabetes, and rheumatic heart disease.
Explore the cellular and molecular basis of heart contraction and conduction, detailing cardiac action potential phases, ion channels, pacemaker and conduction pathways, and cell-to-cell gap junctions.
Explore how neurohormonal activation and diuretic therapy in acute heart failure disrupt sodium, potassium, and magnesium handling, causing hyponatremia, hypokalemia, hypomagnesemia, and hyperkalemia, with management strategies.
Explore how diet and exercise influence heart health, blood pressure, and cholesterol, and learn to follow a dash-style eating plan. Identify heart-healthy foods and avoid refined, high-sodium, and saturated-fat options.
Learn a comprehensive, team-based approach to heart failure care, optimizing evidence-based drugs, adherence, comorbidity management, device therapy, and patient-centered planning for better outcomes.
Explore current heart failure management, including neurohormonal therapies and devices, and future directions like personalized medicine, pharmacogenomics, and telemonitoring to reduce mortality and hospitalizations.
Explain the evolving diagnosis and management of HFpEF and HFmrEF with SGLT2 inhibitors, GLP-1 agonists, MRAs, and ARNI, plus lifestyle and personalized guidelines.
Examine sudden cardiac death risk across hypertrophic cardiomyopathy, arrhythmogenic right ventricular dysplasia, and Brugada syndrome, using ECG markers such as epsilon waves, QT variants, and risk scoring.
Explore arrhythmogenic right ventricular dysplasia, a cardiomyopathy with fibrofatty replacement of the right ventricle, epsilon waves on ECG, and risk of ventricular tachycardia and sudden death.
diabetes significantly increases heart failure risk and worsens mortality and morbidity; the lecture explores the role of arni inhibitors in diabetic heart failure and their impact on patient outcomes.
Explain cardio-renal syndrome and how SGLT2 inhibitors, especially dapagliflozin, improve heart failure and CKD outcomes, with evidence from major trials and guideline adoption.
Discover how SGLT2 inhibitors treat heart failure by blocking kidney sodium reabsorption, causing natriuresis and diuresis, and reducing remodeling and fibrosis, with guideline support across ejection fraction.
Explores updates in heart failure management with SGLT2 inhibitors, comparing dapagliflozin and DELIVER versus EMPEROR data across reduced and preserved ejection fraction, with safety and hospitalization outcomes.
Explore left bundle branch pacing as an alternative to CRT in heart failure management, comparing approaches and outlining potential clinical implications.
Learn how surface ECG guides bi-ventricular pacing in CRT, from coronary venous system leads to axis changes, ventricular fusion patterns, and optimization in heart failure patients.
Identify indications for cardiac resynchronisation therapy in heart failure, including left bundle branch block and ejection fraction less than 35 percent after optimized medical therapy.
Discover crt implantation within the scope of heart failure management, focusing on the fundamentals of cardiac resynchronization therapy and its clinical application.
Advance the sheath and wires to access the right atrium or ventricle, then position the pacing lead to achieve selective or nonselective his bundle capture.
Discover the 2025 updates in heart failure diagnosis and management, emphasizing four pillars of hfref therapy—arni, beta-blockers, mras, sglt2 inhibitors—and the shift to personalized, rapid treatment.
The Clinician's Secret Arsenal: Conquer HF Diagnosis, 2026 Therapies & Readmission Reduction
"Clinician's Secret Arsenal" creates a curiosity gap and exclusivity, making readers feel they're accessing hidden knowledge others miss. Specific outcomes like "Conquer HF Diagnosis" and "Readmission Reduction" promise transformation, leveraging loss aversion by implying better patient results without it. "2026 Therapies" adds urgency and novelty for cutting-edge appeal.
New Description
Discover the hidden triggers silently destroying hearts—and the proven strategies every cardiologist must master to reverse them before it's too late.
This Diploma in Cardiology (Heart Failure & Management) delivers your exclusive playbook: from rapid diagnosis decoding to next-gen therapies slashing readmissions by 30%.
What if one overlooked insight could transform your HF outcomes overnight? Inside, unlock:
Life-saving assessment frameworks used in top UK hospitals
2026 pharmacotherapy breakthroughs + device integration
Your bonus clinical reference book—yours to keep forever
Join 1,000+ clinicians who've elevated their practice. Enroll now—secure your edge and the diploma that sets you apart. Limited spots for this comprehensive certification.
Enhance your confidence on the ward, in clinic, and at MDT by following step‑by‑step, real‑world algorithms you can apply on your very next shift. You will move from uncertainty to structured decision‑making in acute and chronic HF, with practical pearls distilled from complex guidelines into clear, memorable actions.